Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies (original) (raw)

• Hancock, R.E.W. & Lehrer, R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16, 82–88 (1998).
  Article CAS Google Scholar
• Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415, 389–395 (2002).
  Article CAS Google Scholar
• Oppenheim, J.J. & Yang, D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359–365 (2005).
  Article CAS Google Scholar
• Bowdish, D.M.E., Davidson, D.J. & Hancock, R.E.W. A re-evaluation of the role of host defense peptides in mammalian immunity. Curr. Protein Pept. Sci. 6, 35–51 (2005).
  Article CAS Google Scholar
• http://www.bbcm.univ.trieste.it/∼tossi/amsdb.html
• Emes, R.D., Goodstadt, L., Winter, E.E. & Ponting, C.P. Comparison of the genomes of human and mouse lays the foundation of genome zoology. Hum. Mol. Genet. 12, 701–709 (2003).
  Article CAS Google Scholar
• Patil, A., Hughes, A.L. & Zhang, G. Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes. Physiol. Genomics 20, 1–11 (2004).
  Article CAS Google Scholar
• Crovella, S. et al. Primate beta-defensins - structure, function and evolution. Curr. Protein Pept. Sci. 6, 7–21 (2005).
  Article CAS Google Scholar
• Peschel, A. & Sahl, H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4, 529–536 (2006).
  Article CAS Google Scholar
• Yount, N.Y. & Yeaman M.R. Structural congruence among membrane-active host defense polypeptides of diverse phylogeny. Biochim. Biophys. Acta 9, 1373–1386 (2006).
  Article Google Scholar
• McAuliffe, O., Ross, R.P. & Hill, C. Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev. 25, 285–308 (2001).
  Article CAS Google Scholar
• Hsu, S.T. et al. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11, 963–967 (2004).
  Article CAS Google Scholar
• Finking, R. & Marahiel, M.A. Biosynthesis of nonribosomal peptides. Annu. Rev. Microbiol. 58, 453–488 (2004).
  Article CAS Google Scholar
• Coulter, S.N. et al. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. Microbiol. 30, 393–404 (1998).
  Article CAS Google Scholar
• Jenssen, H., Hamill, P. & Hancock, R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491–511 (2006).
  Article CAS Google Scholar
• Yeaman, M.R. & Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27–55 (2003).
  Article CAS Google Scholar
• Sahl, H.G. et al. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 77, 466–475 (2005).
  Article CAS Google Scholar
• Brazas, M.D. & Hancock, R.E.W. Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov. Today 10, 1245–1252 (2005).
  Article CAS Google Scholar
• Perron, G.G., Zasloff, M. & Bell, G. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273, 251–256 (2006).
  Article CAS Google Scholar
• Samuelsen, O. et al. Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. FEBS Lett. 579, 3421–3426 (2005).
  Article CAS Google Scholar
• Breukink, E. & de Kruijff, B. Lipid II as a target for antibiotics. Nat. Rev. Drug Discov. 5, 321–332 (2006).
  Article CAS Google Scholar
• Zhang, L. & Falla, T.J. Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. 7, 653–663 (2006).
  Article CAS Google Scholar
• Lau, Y.E. et al. Interaction and cellular localization of the human host defense peptide, LL-37, with lung epithelial cells. Infect. Immun. 73, 583–591 (2005).
  Article CAS Google Scholar
• Sandgren, S. et al. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 279, 17951–17956 (2004).
  Article CAS Google Scholar
• McPhee, J.B., Scott, M.G. & Hancock, R.E.W. Design of host defence peptides for antimicrobial and immunity enhancing activities. Comb. Chem. High Throughput Screen. 8, 257–272 (2005).
  Article CAS Google Scholar
• Mygind, P.H. et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437, 975–980 (2005).
  Article CAS Google Scholar
• Cotter, P.D., Hill, C. & Ross, R.P. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3, 777–788 (2005).
  Article CAS Google Scholar
• Hilpert, K., Volkmer-Engert, R., Walter, T. & Hancock, R.E.W. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23, 1008–1012 (2005).
  Article CAS Google Scholar
• Blondelle, S.E. & Houghten, R.A. Novel antimicrobial compounds identified using synthetic combinatorial library technology. Trends Biotechnol. 14, 60–65 (1996).
  Article CAS Google Scholar
• Freidinger, R.M. et al. Design and synthesis of novel bioactive peptides and peptidomimetics. J. Med. Chem. 46, 5553–5566 (2003).
  Article CAS Google Scholar
• Masip, I., Perez-Paya, E. & Messeguer, A. Peptoids as source of compounds eliciting antibacterial activity. Comb. Chem. High Throughput Screen. 8, 235–239 (2005).
  Article CAS Google Scholar
• Robinson, J.A. et al. Properties and structure-activity studies of cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial peptide protegrin I. Bioorg. Med. Chem. 13, 2055–2064 (2005).
  Article CAS Google Scholar
• Porter, E.A., Wang, X., Lee, H.S., Weisblum, B. & Gellman, S.H. Non-haemolytic beta-amino-acid oligomers. Nature 404, 565 (2000).
  Article CAS Google Scholar
• Marshall, N.J., Andruszkiewicz, R., Gupta, S., Milewski, S. & Payne, J.W. Structure-activity relationships for a series of peptidomimetic antimicrobial prodrugs containing glutamine analogues. J. Antimicrob. Chemother. 51, 821–831 (2003).
  Article CAS Google Scholar
• Xie, L. et al. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science 303, 679–681 (2004).
  Article CAS Google Scholar
• Rink, R., et al. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes. Biochem. 44, 8873–8882 (2005).
  Article CAS Google Scholar
• Finlay, B.B. & Hancock, R.E.W. Can innate immunity be enhanced to treat infections? Nat. Rev. Microbiol. 2, 497–504 (2004).
  Article CAS Google Scholar
• O'Neill, L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3–9 (2006).
  Article CAS Google Scholar
• Bowdish, D.M.E. et al. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77, 451–459 (2005).
  Article CAS Google Scholar
• Zhang, L. et al. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 49, 2921–2927 (2005).
  Article CAS Google Scholar